-
Mashup Score: 4Primary VTE Prevention for Patients with Cancer - 4 month(s) ago
Based on results from randomized trials, current guidelines recommend primary prophylaxis against venous thromboembolism (VTE) for high-risk
Source: www.jwatch.orgCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 4
Studies of the anti–PD-1 immune checkpoint inhibitor pembrolizumab in patients with gastric cancer have had mixed results. Investigators now report
Source: www.jwatch.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 5Tislelizumab vs. Sorafenib for Unresectable Hepatocellular Cancer - 6 month(s) ago
First-line treatment for patients with unresectable hepatocellular cancer (HCC) is either combination immunotherapy with bevacizumab and atezolizumab
Source: www.jwatch.orgCategories: General Medicine News, General Journals & SocietTweet
-
Mashup Score: 0The Biomarker Toolkit — an evidence-based guideline to predict cancer biomarker success and guide development - BMC Medicine - 7 month(s) ago
Background An increased number of resources are allocated on cancer biomarker discovery, but very few of these biomarkers are clinically adopted. To bridge the gap between Biomarker discovery and clinical use, we aim to generate the Biomarker Toolkit, a tool designed to identify clinically promising biomarkers and promote successful biomarker translation. Methods All features associated with a clinically useful biomarker were identified using mixed-methodology, including systematic literature search, semi-structured interviews, and an online two-stage Delphi-Survey. Validation of the checklist was achieved by independent systematic literature searches using keywords/subheadings related to clinically and non-clinically utilised breast and colorectal cancer biomarkers. Composite aggregated scores were generated for each selected publication based on the presence/absence of an attribute listed in the Biomarker Toolkit checklist. Results Systematic literature search identified 129 attribut
Source: bmcmedicine.biomedcentral.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 10NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals - 10 month(s) ago
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Source: www.jwatch.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
Background Human epidermal growth factor receptor 2 (HER2) targeted therapy combined with endocrine therapy has been recommended as an alternative treatment strategy for patients with hormone receptor (HR)-positive, HER2-positive metastatic breast cancer (MBC). This study aimed to evaluate the role of pyrotinib, an oral pan-HER irreversible tyrosine kinase inhibitor, in combination with letrozole…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals - 10 month(s) ago
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Source: www.jwatch.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0New Ovarian Cancer Drug Extends Survival in Resistant Disease - 11 month(s) ago
‘Practice changing’ findings for tough-to-treat patient population
Source: www.medpagetoday.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0
Survival 13 months better with surgery, but ‘curiosities’ in neoadjuvant arm muddy the results
Source: www.medpagetoday.comCategories: Latest Headlines, Oncologists2Tweet
-
Mashup Score: 0NEJM Journal Watch: Summaries of and commentary on original medical and scientific articles from key medical journals - 11 month(s) ago
NEJM Journal Watch reviews over 250 scientific and medical journals to present important clinical research findings and insightful commentary
Source: www.jwatch.orgCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
Primary prophylaxis in high-risk patients with lung or gastrointestinal cancers lowered incidence of thromboembolism in a randomized trial. https://t.co/Gl331DSfzs @DresslerDD #OncoTwitter https://t.co/j2WV3wGZx1